IL286670B2 - תרכובות להשראת יצירת רקמות ושימושיהן - Google Patents

Info

Publication number

IL286670B2

IL286670B2 IL286670A IL28667021A IL286670B2 IL 286670 B2 IL286670 B2 IL 286670B2 IL 286670 A IL286670 A IL 286670A IL 28667021 A IL28667021 A IL 28667021A IL 286670 B2 IL286670 B2 IL 286670B2

Authority

IL

Israel

Prior art keywords

spis

peptide

lyy

eplt

ssls

Prior art date

2015-08-25

Links

• Espacenet
• Global Dossier
• Discuss

• 230000001939 inductive effect Effects 0.000 title claims description 180
• 230000009772 tissue formation Effects 0.000 title claims description 40
• 150000001875 compounds Chemical class 0.000 title description 177
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 297
• 210000004027 cell Anatomy 0.000 claims description 249
• 150000001413 amino acids Chemical class 0.000 claims description 217
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 216
• 210000000130 stem cell Anatomy 0.000 claims description 213
• 230000004069 differentiation Effects 0.000 claims description 186
• 241000711981 Sais Species 0.000 claims description 144
• 201000010099 disease Diseases 0.000 claims description 127
• 229910052717 sulfur Inorganic materials 0.000 claims description 108
• 230000007850 degeneration Effects 0.000 claims description 103
• 210000001519 tissue Anatomy 0.000 claims description 94
• 208000035475 disorder Diseases 0.000 claims description 89
• 230000001737 promoting effect Effects 0.000 claims description 85
• 230000007170 pathology Effects 0.000 claims description 82
• 238000011069 regeneration method Methods 0.000 claims description 73
• 239000000816 peptidomimetic Substances 0.000 claims description 69
• 229910052739 hydrogen Inorganic materials 0.000 claims description 68
• 238000000034 method Methods 0.000 claims description 68
• 101800000936 Structural peptide 4 Proteins 0.000 claims description 62
• 102100028290 Vacuolar protein sorting-associated protein 29 Human genes 0.000 claims description 62
• 229910052731 fluorine Inorganic materials 0.000 claims description 61
• 230000008929 regeneration Effects 0.000 claims description 56
• 229910052740 iodine Inorganic materials 0.000 claims description 53
• 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 49
• 230000002708 enhancing effect Effects 0.000 claims description 44
• 230000017423 tissue regeneration Effects 0.000 claims description 44
• 229910052727 yttrium Inorganic materials 0.000 claims description 41
• 210000001525 retina Anatomy 0.000 claims description 38
• 210000002435 tendon Anatomy 0.000 claims description 38
• 210000003780 hair follicle Anatomy 0.000 claims description 35
• 210000003041 ligament Anatomy 0.000 claims description 33
• 102000009465 Growth Factor Receptors Human genes 0.000 claims description 31
• 108010009202 Growth Factor Receptors Proteins 0.000 claims description 31
• 229910052698 phosphorus Inorganic materials 0.000 claims description 31
• 229910052700 potassium Inorganic materials 0.000 claims description 29
• 101000701051 Legionella pneumophila Zinc metalloproteinase Proteins 0.000 claims description 28
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 28
• 208000001132 Osteoporosis Diseases 0.000 claims description 23
• 230000033115 angiogenesis Effects 0.000 claims description 21
• 239000012620 biological material Substances 0.000 claims description 20
• 230000035558 fertility Effects 0.000 claims description 20
• 229910052720 vanadium Inorganic materials 0.000 claims description 19
• 239000000203 mixture Substances 0.000 claims description 18
• 229910052721 tungsten Inorganic materials 0.000 claims description 15
• 208000007984 Female Infertility Diseases 0.000 claims description 14
• 206010021928 Infertility female Diseases 0.000 claims description 14
• 230000000975 bioactive effect Effects 0.000 claims description 14
• 230000003907 kidney function Effects 0.000 claims description 14
• 206010008723 Chondrodystrophy Diseases 0.000 claims description 13
• 206010011219 Costochondritis Diseases 0.000 claims description 13
• 206010056677 Nerve degeneration Diseases 0.000 claims description 13
• 206010065159 Polychondritis Diseases 0.000 claims description 13
• 208000026317 Tietze syndrome Diseases 0.000 claims description 13
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 13
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 13
• 208000008919 achondroplasia Diseases 0.000 claims description 13
• 201000008482 osteoarthritis Diseases 0.000 claims description 13
• 208000009169 relapsing polychondritis Diseases 0.000 claims description 13
• 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 12
• 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 12
• 102000009618 Transforming Growth Factors Human genes 0.000 claims description 11
• 108010009583 Transforming Growth Factors Proteins 0.000 claims description 11
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 10
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 10
• 230000024245 cell differentiation Effects 0.000 claims description 10
• 239000003814 drug Substances 0.000 claims description 10
• 238000000338 in vitro Methods 0.000 claims description 10
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 9
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 9
• 210000001612 chondrocyte Anatomy 0.000 claims description 9
• 208000020832 chronic kidney disease Diseases 0.000 claims description 9
• 229940126864 fibroblast growth factor Drugs 0.000 claims description 9
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 9
• 230000003698 anagen phase Effects 0.000 claims description 8
• 238000001727 in vivo Methods 0.000 claims description 8
• 206010043554 thrombocytopenia Diseases 0.000 claims description 8
• 201000004384 Alopecia Diseases 0.000 claims description 7
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims description 7
• 208000034841 Thrombotic Microangiopathies Diseases 0.000 claims description 7
• 229940079593 drug Drugs 0.000 claims description 7
• 230000035800 maturation Effects 0.000 claims description 7
• 230000011164 ossification Effects 0.000 claims description 7
• 210000004409 osteocyte Anatomy 0.000 claims description 7
• 206010006451 bronchitis Diseases 0.000 claims description 6
• 230000022159 cartilage development Effects 0.000 claims description 6
• 238000000968 medical method and process Methods 0.000 claims description 6
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 5
• 102000000589 Interleukin-1 Human genes 0.000 claims description 5
• 108010002352 Interleukin-1 Proteins 0.000 claims description 5
• 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 claims description 5
• 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 claims description 5
• 201000009805 cryptogenic organizing pneumonia Diseases 0.000 claims description 5
• 206010020718 hyperplasia Diseases 0.000 claims description 5
• 210000003734 kidney Anatomy 0.000 claims description 5
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 5
• 208000008190 Agammaglobulinemia Diseases 0.000 claims description 4
• 208000001640 Fibromyalgia Diseases 0.000 claims description 4
• 206010020983 Hypogammaglobulinaemia Diseases 0.000 claims description 4
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 4
• 208000010378 Pulmonary Embolism Diseases 0.000 claims description 4
• 208000007536 Thrombosis Diseases 0.000 claims description 4
• 208000007502 anemia Diseases 0.000 claims description 4
• 230000020411 cell activation Effects 0.000 claims description 4
• 206010035653 pneumoconiosis Diseases 0.000 claims description 4
• 230000000069 prophylactic effect Effects 0.000 claims description 4
• 201000002793 renal fibrosis Diseases 0.000 claims description 4
• 208000011580 syndromic disease Diseases 0.000 claims description 4
• 208000002485 Adiposis dolorosa Diseases 0.000 claims description 3
• 206010001766 Alopecia totalis Diseases 0.000 claims description 3
• 206010001767 Alopecia universalis Diseases 0.000 claims description 3
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 claims description 3
• 201000001320 Atherosclerosis Diseases 0.000 claims description 3
• 201000006935 Becker muscular dystrophy Diseases 0.000 claims description 3
• 208000001593 Bernard-Soulier syndrome Diseases 0.000 claims description 3
• 208000025678 Ciliary Motility disease Diseases 0.000 claims description 3
• 208000028702 Congenital thrombocyte disease Diseases 0.000 claims description 3
• 208000003024 Diffuse alopecia Diseases 0.000 claims description 3
• 102400001368 Epidermal growth factor Human genes 0.000 claims description 3
• 101800003838 Epidermal growth factor Proteins 0.000 claims description 3
• 208000032027 Essential Thrombocythemia Diseases 0.000 claims description 3
• 208000010463 Familial multiple lipomatosis Diseases 0.000 claims description 3
• 102000004864 Fibroblast growth factor 10 Human genes 0.000 claims description 3
• 108090001047 Fibroblast growth factor 10 Proteins 0.000 claims description 3
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 claims description 3
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 claims description 3
• 208000024869 Goodpasture syndrome Diseases 0.000 claims description 3
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims description 3
• 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 claims description 3
• 208000028622 Immune thrombocytopenia Diseases 0.000 claims description 3
• 208000032571 Infant acute respiratory distress syndrome Diseases 0.000 claims description 3
• 208000029523 Interstitial Lung disease Diseases 0.000 claims description 3
• 208000001984 Multiple Symmetrical Lipomatosis Diseases 0.000 claims description 3
• 206010028974 Neonatal respiratory distress syndrome Diseases 0.000 claims description 3
• 206010067472 Organising pneumonia Diseases 0.000 claims description 3
• 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims description 3
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 3
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 3
• 208000006110 Wiskott-Aldrich syndrome Diseases 0.000 claims description 3
• 208000004631 alopecia areata Diseases 0.000 claims description 3
• 208000032775 alopecia universalis congenita Diseases 0.000 claims description 3
• 201000002996 androgenic alopecia Diseases 0.000 claims description 3
• 230000003376 axonal effect Effects 0.000 claims description 3
• 208000022605 chemotherapy-induced alopecia Diseases 0.000 claims description 3
• 208000009190 disseminated intravascular coagulation Diseases 0.000 claims description 3
• 229940116977 epidermal growth factor Drugs 0.000 claims description 3
• 230000002757 inflammatory effect Effects 0.000 claims description 3
• 201000011171 multiple symmetric lipomatosis Diseases 0.000 claims description 3
• 230000004770 neurodegeneration Effects 0.000 claims description 3
• 201000002652 newborn respiratory distress syndrome Diseases 0.000 claims description 3
• 201000009266 primary ciliary dyskinesia Diseases 0.000 claims description 3
• 230000000241 respiratory effect Effects 0.000 claims description 3
• 201000001297 telogen effluvium Diseases 0.000 claims description 3
• 201000003067 thrombocytopenia due to platelet alloimmunization Diseases 0.000 claims description 3
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 2
• 201000010000 Agranulocytosis Diseases 0.000 claims description 2
• 208000030760 Anaemia of chronic disease Diseases 0.000 claims description 2
• 208000032467 Aplastic anaemia Diseases 0.000 claims description 2
• 208000033116 Asbestos intoxication Diseases 0.000 claims description 2
• 208000000412 Avitaminosis Diseases 0.000 claims description 2
• 206010006448 Bronchiolitis Diseases 0.000 claims description 2
• 206010006458 Bronchitis chronic Diseases 0.000 claims description 2
• 208000007596 Byssinosis Diseases 0.000 claims description 2
• 241000223205 Coccidioides immitis Species 0.000 claims description 2
• 208000019707 Cryoglobulinemic vasculitis Diseases 0.000 claims description 2
• 201000003883 Cystic fibrosis Diseases 0.000 claims description 2
• 206010051055 Deep vein thrombosis Diseases 0.000 claims description 2
• 208000035810 Denervation atrophy Diseases 0.000 claims description 2
• 206010014561 Emphysema Diseases 0.000 claims description 2
• 206010014940 Eosinopenia Diseases 0.000 claims description 2
• 206010014950 Eosinophilia Diseases 0.000 claims description 2
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 claims description 2
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 2
• 206010016654 Fibrosis Diseases 0.000 claims description 2
• 208000013607 Glanzmann thrombasthenia Diseases 0.000 claims description 2
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims description 2
• 208000031220 Hemophilia Diseases 0.000 claims description 2
• 208000009292 Hemophilia A Diseases 0.000 claims description 2
• 206010062506 Heparin-induced thrombocytopenia Diseases 0.000 claims description 2
• 201000002563 Histoplasmosis Diseases 0.000 claims description 2
• 206010048643 Hypereosinophilic syndrome Diseases 0.000 claims description 2
• 206010021135 Hypovitaminosis Diseases 0.000 claims description 2
• 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims description 2
• 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 claims description 2
• 208000015710 Iron-Deficiency Anemia Diseases 0.000 claims description 2
• 208000004554 Leishmaniasis Diseases 0.000 claims description 2
• 206010024558 Lip oedema Diseases 0.000 claims description 2
• 208000007021 Lipedema Diseases 0.000 claims description 2
• 206010049287 Lipodystrophy acquired Diseases 0.000 claims description 2
• 206010027406 Mesothelioma Diseases 0.000 claims description 2
• 208000007101 Muscle Cramp Diseases 0.000 claims description 2
• 208000010428 Muscle Weakness Diseases 0.000 claims description 2
• 208000021642 Muscular disease Diseases 0.000 claims description 2
• 206010028372 Muscular weakness Diseases 0.000 claims description 2
• 208000000112 Myalgia Diseases 0.000 claims description 2
• 201000009623 Myopathy Diseases 0.000 claims description 2
• 208000008589 Obesity Diseases 0.000 claims description 2
• 208000031845 Pernicious anaemia Diseases 0.000 claims description 2
• 201000005702 Pertussis Diseases 0.000 claims description 2
• 208000002151 Pleural effusion Diseases 0.000 claims description 2
• 206010035664 Pneumonia Diseases 0.000 claims description 2
• 206010037423 Pulmonary oedema Diseases 0.000 claims description 2
• 206010053879 Sepsis syndrome Diseases 0.000 claims description 2
• 201000010001 Silicosis Diseases 0.000 claims description 2
• 102000013275 Somatomedins Human genes 0.000 claims description 2
• 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 claims description 2
• 208000002903 Thalassemia Diseases 0.000 claims description 2
• 201000007023 Thrombotic Thrombocytopenic Purpura Diseases 0.000 claims description 2
• 201000005485 Toxoplasmosis Diseases 0.000 claims description 2
• 206010047249 Venous thrombosis Diseases 0.000 claims description 2
• 208000027276 Von Willebrand disease Diseases 0.000 claims description 2
• 208000017733 acquired polycythemia vera Diseases 0.000 claims description 2
• 208000022400 anemia due to chronic disease Diseases 0.000 claims description 2
• 239000002870 angiogenesis inducing agent Substances 0.000 claims description 2
• 206010003441 asbestosis Diseases 0.000 claims description 2
• 208000006673 asthma Diseases 0.000 claims description 2
• 208000020538 atrophic muscular disease Diseases 0.000 claims description 2
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims description 2
• 201000009267 bronchiectasis Diseases 0.000 claims description 2
• 206010006475 bronchopulmonary dysplasia Diseases 0.000 claims description 2
• 208000007451 chronic bronchitis Diseases 0.000 claims description 2
• 230000001684 chronic effect Effects 0.000 claims description 2
• 201000003486 coccidioidomycosis Diseases 0.000 claims description 2
• 230000000295 complement effect Effects 0.000 claims description 2
• 201000003278 cryoglobulinemia Diseases 0.000 claims description 2
• 201000001155 extrinsic allergic alveolitis Diseases 0.000 claims description 2
• 206010016256 fatigue Diseases 0.000 claims description 2
• 230000004761 fibrosis Effects 0.000 claims description 2
• 208000007475 hemolytic anemia Diseases 0.000 claims description 2
• 208000022098 hypersensitivity pneumonitis Diseases 0.000 claims description 2
• 208000024364 idiopathic hypereosinophilic syndrome Diseases 0.000 claims description 2
• 208000036971 interstitial lung disease 2 Diseases 0.000 claims description 2
• 201000002364 leukopenia Diseases 0.000 claims description 2
• 231100001022 leukopenia Toxicity 0.000 claims description 2
• 208000006132 lipodystrophy Diseases 0.000 claims description 2
• 201000004792 malaria Diseases 0.000 claims description 2
• 230000001404 mediated effect Effects 0.000 claims description 2
• 208000013465 muscle pain Diseases 0.000 claims description 2
• 201000000585 muscular atrophy Diseases 0.000 claims description 2
• 201000006938 muscular dystrophy Diseases 0.000 claims description 2
• 235000020824 obesity Nutrition 0.000 claims description 2
• 201000003144 pneumothorax Diseases 0.000 claims description 2
• 208000037244 polycythemia vera Diseases 0.000 claims description 2
• 208000005333 pulmonary edema Diseases 0.000 claims description 2
• 230000002685 pulmonary effect Effects 0.000 claims description 2
• 208000005069 pulmonary fibrosis Diseases 0.000 claims description 2
• 208000002815 pulmonary hypertension Diseases 0.000 claims description 2
• 201000000306 sarcoidosis Diseases 0.000 claims description 2
• 208000007056 sickle cell anemia Diseases 0.000 claims description 2
• 201000002859 sleep apnea Diseases 0.000 claims description 2
• 201000008827 tuberculosis Diseases 0.000 claims description 2
• 208000030401 vitamin deficiency disease Diseases 0.000 claims description 2
• 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 claims description 2
• 101000782453 Homo sapiens Vacuolar protein sorting-associated protein 18 homolog Proteins 0.000 claims 3
• 108010088535 Pep-1 peptide Proteins 0.000 claims 3
• 102100035870 Vacuolar protein sorting-associated protein 18 homolog Human genes 0.000 claims 3
• 238000003384 imaging method Methods 0.000 claims 3
• 101000743353 Homo sapiens Vacuolar protein sorting-associated protein 11 homolog Proteins 0.000 claims 2
• 101150113139 PEP12 gene Proteins 0.000 claims 2
• 102100038309 Vacuolar protein sorting-associated protein 11 homolog Human genes 0.000 claims 2
• SRCAXTIBNLIRHU-JJKPAIEPSA-N lantibiotic pep5 Chemical compound N([C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N\C(=C/C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N\C(=C(/C)S)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)C(=O)CC SRCAXTIBNLIRHU-JJKPAIEPSA-N 0.000 claims 2
• 208000006029 Cardiomegaly Diseases 0.000 claims 1
• 208000031229 Cardiomyopathies Diseases 0.000 claims 1
• 208000002330 Congenital Heart Defects Diseases 0.000 claims 1
• 201000006306 Cor pulmonale Diseases 0.000 claims 1
• 206010019280 Heart failures Diseases 0.000 claims 1
• 208000009525 Myocarditis Diseases 0.000 claims 1
• 208000005764 Peripheral Arterial Disease Diseases 0.000 claims 1
• 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 1
• 208000004186 Pulmonary Heart Disease Diseases 0.000 claims 1
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
• 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
• 206010003119 arrhythmia Diseases 0.000 claims 1
• 208000026106 cerebrovascular disease Diseases 0.000 claims 1
• 208000028831 congenital heart disease Diseases 0.000 claims 1
• 208000029078 coronary artery disease Diseases 0.000 claims 1
• 238000002405 diagnostic procedure Methods 0.000 claims 1
• 206010014665 endocarditis Diseases 0.000 claims 1
• 208000019622 heart disease Diseases 0.000 claims 1
• 208000018578 heart valve disease Diseases 0.000 claims 1
• 208000015210 hypertensive heart disease Diseases 0.000 claims 1
• 210000004523 ligament cell Anatomy 0.000 claims 1
• 230000007514 neuronal growth Effects 0.000 claims 1
• 238000004806 packaging method and process Methods 0.000 claims 1
• 101150096366 pep7 gene Proteins 0.000 claims 1
• 208000004124 rheumatic heart disease Diseases 0.000 claims 1
• 229940024606 amino acid Drugs 0.000 description 211
• 235000001014 amino acid Nutrition 0.000 description 211
• 230000008094 contradictory effect Effects 0.000 description 93
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 75
• 210000003491 skin Anatomy 0.000 description 68
• 210000000988 bone and bone Anatomy 0.000 description 62
• 229910052799 carbon Inorganic materials 0.000 description 54
• 210000001744 T-lymphocyte Anatomy 0.000 description 50
• 239000003102 growth factor Substances 0.000 description 41
• 230000029663 wound healing Effects 0.000 description 41
• 230000008569 process Effects 0.000 description 40
• 230000001172 regenerating effect Effects 0.000 description 39
• 208000035139 partial with pericentral spikes epilepsy Diseases 0.000 description 36
• 210000000845 cartilage Anatomy 0.000 description 34
• 108090000623 proteins and genes Proteins 0.000 description 32
• 239000000126 substance Substances 0.000 description 31
• 210000004072 lung Anatomy 0.000 description 30
• 230000008439 repair process Effects 0.000 description 30
• 230000015572 biosynthetic process Effects 0.000 description 28
• 235000018102 proteins Nutrition 0.000 description 28
• 102000004169 proteins and genes Human genes 0.000 description 28
• 210000000963 osteoblast Anatomy 0.000 description 27
• 210000002569 neuron Anatomy 0.000 description 26
• 230000003247 decreasing effect Effects 0.000 description 25
• 238000011161 development Methods 0.000 description 25
• 230000018109 developmental process Effects 0.000 description 25
• 239000002243 precursor Substances 0.000 description 24
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 22
• 210000002950 fibroblast Anatomy 0.000 description 22
• 230000003993 interaction Effects 0.000 description 20
• 230000033458 reproduction Effects 0.000 description 20
• 230000001413 cellular effect Effects 0.000 description 18
• 230000003213 activating effect Effects 0.000 description 17
• 230000000694 effects Effects 0.000 description 17
• 230000002207 retinal effect Effects 0.000 description 17
• -1 2-pentyl Chemical group 0.000 description 15
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 15
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 15
• 210000002449 bone cell Anatomy 0.000 description 15
• 229940112869 bone morphogenetic protein Drugs 0.000 description 15
• 210000003321 cartilage cell Anatomy 0.000 description 15
• 230000014509 gene expression Effects 0.000 description 15
• 230000003779 hair growth Effects 0.000 description 15
• 230000011664 signaling Effects 0.000 description 15
• 210000005167 vascular cell Anatomy 0.000 description 15
• 241000282414 Homo sapiens Species 0.000 description 14
• 230000006870 function Effects 0.000 description 14
• 210000005265 lung cell Anatomy 0.000 description 14
• 230000005012 migration Effects 0.000 description 14
• 238000013508 migration Methods 0.000 description 14
• 229920000642 polymer Polymers 0.000 description 14
• 229920001184 polypeptide Polymers 0.000 description 14
• 238000011282 treatment Methods 0.000 description 14
• 210000004369 blood Anatomy 0.000 description 13
• 239000012071 phase Substances 0.000 description 13
• 239000000047 product Substances 0.000 description 13
• 230000037303 wrinkles Effects 0.000 description 13
• 208000012641 Pigmentation disease Diseases 0.000 description 12
• 210000001789 adipocyte Anatomy 0.000 description 12
• 125000004429 atom Chemical group 0.000 description 12
• 239000008280 blood Substances 0.000 description 12
• 210000001185 bone marrow Anatomy 0.000 description 12
• 230000012010 growth Effects 0.000 description 12
• 210000000442 hair follicle cell Anatomy 0.000 description 12
• 210000005003 heart tissue Anatomy 0.000 description 12
• 239000010410 layer Substances 0.000 description 12
• 230000000873 masking effect Effects 0.000 description 12
• 102000005962 receptors Human genes 0.000 description 12
• 108020003175 receptors Proteins 0.000 description 12
• 230000002792 vascular Effects 0.000 description 12
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 11
• 241001465754 Metazoa Species 0.000 description 11
• 210000002889 endothelial cell Anatomy 0.000 description 11
• 230000035876 healing Effects 0.000 description 11
• 208000014674 injury Diseases 0.000 description 11
• 238000002560 therapeutic procedure Methods 0.000 description 11
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 10
• 102000008186 Collagen Human genes 0.000 description 10
• 108010035532 Collagen Proteins 0.000 description 10
• 241000124008 Mammalia Species 0.000 description 10
• 208000027418 Wounds and injury Diseases 0.000 description 10
• 210000004899 c-terminal region Anatomy 0.000 description 10
• 229920001436 collagen Polymers 0.000 description 10
• 230000006378 damage Effects 0.000 description 10
• 230000007547 defect Effects 0.000 description 10
• 210000001178 neural stem cell Anatomy 0.000 description 10
• 238000010186 staining Methods 0.000 description 10
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 9
• 238000004458 analytical method Methods 0.000 description 9
• 230000004071 biological effect Effects 0.000 description 9
• 238000000198 fluorescence anisotropy Methods 0.000 description 9
• 230000002188 osteogenic effect Effects 0.000 description 9
• 230000035755 proliferation Effects 0.000 description 9
• 230000001225 therapeutic effect Effects 0.000 description 9
• CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 8
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 8
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 8
• 108010025020 Nerve Growth Factor Proteins 0.000 description 8
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 8
• 230000004913 activation Effects 0.000 description 8
• 210000004504 adult stem cell Anatomy 0.000 description 8
• 125000000217 alkyl group Chemical group 0.000 description 8
• 210000000601 blood cell Anatomy 0.000 description 8
• 239000000919 ceramic Substances 0.000 description 8
• 210000002615 epidermis Anatomy 0.000 description 8
• 210000002744 extracellular matrix Anatomy 0.000 description 8
• 210000003205 muscle Anatomy 0.000 description 8
• 230000001105 regulatory effect Effects 0.000 description 8
• 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 7
• 102000040945 Transcription factor Human genes 0.000 description 7
• 108091023040 Transcription factor Proteins 0.000 description 7
• 230000000875 corresponding effect Effects 0.000 description 7
• 210000004207 dermis Anatomy 0.000 description 7
• 238000010586 diagram Methods 0.000 description 7
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 7
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 7
• 210000000056 organ Anatomy 0.000 description 7
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 7
• 230000022379 skeletal muscle tissue development Effects 0.000 description 7
• 238000003786 synthesis reaction Methods 0.000 description 7
• 208000010392 Bone Fractures Diseases 0.000 description 6
• 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 6
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
• 206010017076 Fracture Diseases 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 102000004584 Somatomedin Receptors Human genes 0.000 description 6
• 108010017622 Somatomedin Receptors Proteins 0.000 description 6
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 6
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
• 239000000412 dendrimer Substances 0.000 description 6
• 229920000736 dendritic polymer Polymers 0.000 description 6
• 230000002500 effect on skin Effects 0.000 description 6
• 239000000835 fiber Substances 0.000 description 6
• 210000004209 hair Anatomy 0.000 description 6
• 239000000017 hydrogel Substances 0.000 description 6
• 230000006698 induction Effects 0.000 description 6
• 230000003834 intracellular effect Effects 0.000 description 6
• 230000001009 osteoporotic effect Effects 0.000 description 6
• 239000001301 oxygen Substances 0.000 description 6
• 229910052760 oxygen Inorganic materials 0.000 description 6
• VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 6
• 210000002381 plasma Anatomy 0.000 description 6
• 230000003797 telogen phase Effects 0.000 description 6
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 5
• 102000015775 Core Binding Factor Alpha 1 Subunit Human genes 0.000 description 5
• 108010024682 Core Binding Factor Alpha 1 Subunit Proteins 0.000 description 5
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 5
• 102000015336 Nerve Growth Factor Human genes 0.000 description 5
• 238000011529 RT qPCR Methods 0.000 description 5
• 102000007591 Tartrate-Resistant Acid Phosphatase Human genes 0.000 description 5
• 108010032050 Tartrate-Resistant Acid Phosphatase Proteins 0.000 description 5
• 230000002378 acidificating effect Effects 0.000 description 5
• 210000000577 adipose tissue Anatomy 0.000 description 5
• 125000003275 alpha amino acid group Chemical group 0.000 description 5
• 229910052586 apatite Inorganic materials 0.000 description 5
• 210000004204 blood vessel Anatomy 0.000 description 5
• 239000002537 cosmetic Substances 0.000 description 5
• 230000003511 endothelial effect Effects 0.000 description 5
• 210000003743 erythrocyte Anatomy 0.000 description 5
• 125000000524 functional group Chemical group 0.000 description 5
• 238000003125 immunofluorescent labeling Methods 0.000 description 5
• 238000012423 maintenance Methods 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 229940053128 nerve growth factor Drugs 0.000 description 5
• 102000039446 nucleic acids Human genes 0.000 description 5
• 108020004707 nucleic acids Proteins 0.000 description 5
• 150000007523 nucleic acids Chemical class 0.000 description 5
• 238000010647 peptide synthesis reaction Methods 0.000 description 5
• HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
• 238000001356 surgical procedure Methods 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 4
• 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 4
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 4
• 102000001301 EGF receptor Human genes 0.000 description 4
• 108060006698 EGF receptor Proteins 0.000 description 4
• 241000196324 Embryophyta Species 0.000 description 4
• 108091008794 FGF receptors Proteins 0.000 description 4
• 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 4
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 4
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 4
• 102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 4
• 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 4
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
• 108091008606 PDGF receptors Proteins 0.000 description 4
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 4
• 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 description 4
• 102000008022 Proto-Oncogene Proteins c-met Human genes 0.000 description 4
• 108091008605 VEGF receptors Proteins 0.000 description 4
• 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 4
• 125000000539 amino acid group Chemical group 0.000 description 4
• 230000006907 apoptotic process Effects 0.000 description 4
• 210000001772 blood platelet Anatomy 0.000 description 4
• 238000004422 calculation algorithm Methods 0.000 description 4
• 210000003169 central nervous system Anatomy 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 229910052805 deuterium Inorganic materials 0.000 description 4
• 239000012039 electrophile Substances 0.000 description 4
• 230000013020 embryo development Effects 0.000 description 4
• 238000000605 extraction Methods 0.000 description 4
• 210000004602 germ cell Anatomy 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 210000002510 keratinocyte Anatomy 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 238000000329 molecular dynamics simulation Methods 0.000 description 4
• 210000000653 nervous system Anatomy 0.000 description 4
• 210000004498 neuroglial cell Anatomy 0.000 description 4
• 230000035771 neuroregeneration Effects 0.000 description 4
• 239000012038 nucleophile Substances 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 210000000229 preadipocyte Anatomy 0.000 description 4
• 210000002027 skeletal muscle Anatomy 0.000 description 4
• 210000001057 smooth muscle myoblast Anatomy 0.000 description 4
• 230000004862 vasculogenesis Effects 0.000 description 4
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 3
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 3
• 102000055007 Cartilage Oligomeric Matrix Human genes 0.000 description 3
• 101710176668 Cartilage oligomeric matrix protein Proteins 0.000 description 3
• 102000004127 Cytokines Human genes 0.000 description 3
• 108090000695 Cytokines Proteins 0.000 description 3
• 108020004414 DNA Proteins 0.000 description 3
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 3
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
• 206010020649 Hyperkeratosis Diseases 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 102100030608 Mothers against decapentaplegic homolog 7 Human genes 0.000 description 3
• 102000007072 Nerve Growth Factors Human genes 0.000 description 3
• 208000001164 Osteoporotic Fractures Diseases 0.000 description 3
• 101700026522 SMAD7 Proteins 0.000 description 3
• 108010043267 Sp7 Transcription Factor Proteins 0.000 description 3
• RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
• 102100032317 Transcription factor Sp7 Human genes 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 125000003118 aryl group Chemical group 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 230000004888 barrier function Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000031018 biological processes and functions Effects 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 235000014633 carbohydrates Nutrition 0.000 description 3
• 125000004432 carbon atom Chemical group C* 0.000 description 3
• 239000001569 carbon dioxide Substances 0.000 description 3
• 229910002092 carbon dioxide Inorganic materials 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000004663 cell proliferation Effects 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 210000002808 connective tissue Anatomy 0.000 description 3
• 239000013078 crystal Substances 0.000 description 3
• 235000018417 cysteine Nutrition 0.000 description 3
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• 210000003981 ectoderm Anatomy 0.000 description 3
• 239000007789 gas Substances 0.000 description 3
• 230000013632 homeostatic process Effects 0.000 description 3
• 229930195733 hydrocarbon Natural products 0.000 description 3
• 150000002430 hydrocarbons Chemical class 0.000 description 3
• 230000001771 impaired effect Effects 0.000 description 3
• 230000008676 import Effects 0.000 description 3
• 229910052500 inorganic mineral Inorganic materials 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• 208000002780 macular degeneration Diseases 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 210000003716 mesoderm Anatomy 0.000 description 3
• 235000010755 mineral Nutrition 0.000 description 3
• 239000011707 mineral Substances 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 210000000663 muscle cell Anatomy 0.000 description 3
• 230000001537 neural effect Effects 0.000 description 3
• 210000000440 neutrophil Anatomy 0.000 description 3
• 239000002777 nucleoside Substances 0.000 description 3
• 150000003833 nucleoside derivatives Chemical class 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• 102000040430 polynucleotide Human genes 0.000 description 3
• 108091033319 polynucleotide Proteins 0.000 description 3
• 239000002157 polynucleotide Substances 0.000 description 3
• 229920001282 polysaccharide Polymers 0.000 description 3
• 239000005017 polysaccharide Substances 0.000 description 3
• 150000004804 polysaccharides Chemical class 0.000 description 3
• 238000011002 quantification Methods 0.000 description 3
• 238000002864 sequence alignment Methods 0.000 description 3
• 230000004936 stimulating effect Effects 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 239000010936 titanium Substances 0.000 description 3
• 229910052719 titanium Inorganic materials 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• 230000014616 translation Effects 0.000 description 3
• 230000032258 transport Effects 0.000 description 3
• 230000008733 trauma Effects 0.000 description 3
• 239000013598 vector Substances 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 108010081589 Becaplermin Proteins 0.000 description 2
• 201000004569 Blindness Diseases 0.000 description 2
• 208000014644 Brain disease Diseases 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 239000004215 Carbon black (E152) Substances 0.000 description 2
• 241001432959 Chernes Species 0.000 description 2
• 102000012422 Collagen Type I Human genes 0.000 description 2
• 108010022452 Collagen Type I Proteins 0.000 description 2
• 108010069514 Cyclic Peptides Proteins 0.000 description 2
• 102000001189 Cyclic Peptides Human genes 0.000 description 2
• 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 2
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
• 102000003693 Hedgehog Proteins Human genes 0.000 description 2
• 108090000031 Hedgehog Proteins Proteins 0.000 description 2
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 2
• 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 2
• 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 2
• 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 102000004230 Neurotrophin 3 Human genes 0.000 description 2
• 108090000742 Neurotrophin 3 Proteins 0.000 description 2
• 108090000099 Neurotrophin-4 Proteins 0.000 description 2
• 102100033857 Neurotrophin-4 Human genes 0.000 description 2
• KPKZJLCSROULON-QKGLWVMZSA-N Phalloidin Chemical compound N1C(=O)[C@@H]([C@@H](O)C)NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H](C2)NC(=O)[C@H](C)NC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H]1CSC1=C2C2=CC=CC=C2N1 KPKZJLCSROULON-QKGLWVMZSA-N 0.000 description 2
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 2
• 239000004696 Poly ether ether ketone Substances 0.000 description 2
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
• 101150106167 SOX9 gene Proteins 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• 206010072170 Skin wound Diseases 0.000 description 2
• 206010052428 Wound Diseases 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 210000004982 adipose tissue macrophage Anatomy 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 210000004381 amniotic fluid Anatomy 0.000 description 2
• 206010068168 androgenetic alopecia Diseases 0.000 description 2
• 210000000648 angioblast Anatomy 0.000 description 2
• 230000003712 anti-aging effect Effects 0.000 description 2
• 230000001153 anti-wrinkle effect Effects 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 239000012298 atmosphere Substances 0.000 description 2
• 210000003651 basophil Anatomy 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• 210000002805 bone matrix Anatomy 0.000 description 2
• 210000005013 brain tissue Anatomy 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 150000001721 carbon Chemical group 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 230000003778 catagen phase Effects 0.000 description 2
• 239000006143 cell culture medium Substances 0.000 description 2
• 230000011712 cell development Effects 0.000 description 2
• 230000003915 cell function Effects 0.000 description 2
• 229910052729 chemical element Inorganic materials 0.000 description 2
• 230000009816 chondrogenic differentiation Effects 0.000 description 2
• 230000002648 chondrogenic effect Effects 0.000 description 2
• 239000007822 coupling agent Substances 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• 230000003111 delayed effect Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
• 210000003979 eosinophil Anatomy 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
• 210000004700 fetal blood Anatomy 0.000 description 2
• 230000003328 fibroblastic effect Effects 0.000 description 2
• 239000012634 fragment Substances 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 230000003676 hair loss Effects 0.000 description 2
• 208000024963 hair loss Diseases 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
• 238000002513 implantation Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 210000001208 inner root sheath cell Anatomy 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 210000001161 mammalian embryo Anatomy 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 210000003593 megakaryocyte Anatomy 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 238000001000 micrograph Methods 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 150000002772 monosaccharides Chemical group 0.000 description 2
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 208000015122 neurodegenerative disease Diseases 0.000 description 2
• 230000004766 neurogenesis Effects 0.000 description 2
• 229940032018 neurotrophin 3 Drugs 0.000 description 2
• 125000004433 nitrogen atom Chemical group N* 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 210000001328 optic nerve Anatomy 0.000 description 2
• 210000002997 osteoclast Anatomy 0.000 description 2
• 230000009818 osteogenic differentiation Effects 0.000 description 2
• 230000004819 osteoinduction Effects 0.000 description 2
• 230000002138 osteoinductive effect Effects 0.000 description 2
• 230000026792 palmitoylation Effects 0.000 description 2
• 210000003668 pericyte Anatomy 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 230000035790 physiological processes and functions Effects 0.000 description 2
• 210000002826 placenta Anatomy 0.000 description 2
• 229920000570 polyether Polymers 0.000 description 2
• 229920002530 polyetherether ketone Polymers 0.000 description 2
• 229920000139 polyethylene terephthalate Polymers 0.000 description 2
• 239000005020 polyethylene terephthalate Substances 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 230000000750 progressive effect Effects 0.000 description 2
• 125000006239 protecting group Chemical group 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 238000007634 remodeling Methods 0.000 description 2
• 210000005084 renal tissue Anatomy 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 208000037803 restenosis Diseases 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 230000004491 retinal development Effects 0.000 description 2
• 210000001164 retinal progenitor cell Anatomy 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 230000036560 skin regeneration Effects 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 210000000434 stratum corneum Anatomy 0.000 description 2
• 210000002536 stromal cell Anatomy 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 229920001059 synthetic polymer Polymers 0.000 description 2
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 230000030968 tissue homeostasis Effects 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• 102000003390 tumor necrosis factor Human genes 0.000 description 2
• 230000007306 turnover Effects 0.000 description 2
• 230000007998 vessel formation Effects 0.000 description 2
• 230000000007 visual effect Effects 0.000 description 2
• 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• 125000004398 2-methyl-2-butyl group Chemical group CC(C)(CC)* 0.000 description 1
• 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
• 125000004917 3-methyl-2-butyl group Chemical group CC(C(C)*)C 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• IPJDHSYCSQAODE-UHFFFAOYSA-N 5-chloromethylfluorescein diacetate Chemical compound O1C(=O)C2=CC(CCl)=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 IPJDHSYCSQAODE-UHFFFAOYSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 108010067219 Aggrecans Proteins 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 102100026376 Artemin Human genes 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
• 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
• 208000020084 Bone disease Diseases 0.000 description 1
• 102100028726 Bone morphogenetic protein 10 Human genes 0.000 description 1
• 102100028727 Bone morphogenetic protein 15 Human genes 0.000 description 1
• 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
• 102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
• 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
• 102100022546 Bone morphogenetic protein 8A Human genes 0.000 description 1
• 102100022545 Bone morphogenetic protein 8B Human genes 0.000 description 1
• 229910014455 Ca-Cb Inorganic materials 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 101150065984 Comp gene Proteins 0.000 description 1
• 239000004971 Cross linker Substances 0.000 description 1
• FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 102000004237 Decorin Human genes 0.000 description 1
• 108090000738 Decorin Proteins 0.000 description 1
• 208000005156 Dehydration Diseases 0.000 description 1
• 108010043648 Discoidin Domain Receptors Proteins 0.000 description 1
• 102000002706 Discoidin Domain Receptors Human genes 0.000 description 1
• 102100040897 Embryonic growth/differentiation factor 1 Human genes 0.000 description 1
• 108091008815 Eph receptors Proteins 0.000 description 1
• 206010063560 Excessive granulation tissue Diseases 0.000 description 1
• 102000017177 Fibromodulin Human genes 0.000 description 1
• 108010013996 Fibromodulin Proteins 0.000 description 1
• 206010071602 Genetic polymorphism Diseases 0.000 description 1
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 1
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108010090254 Growth Differentiation Factor 5 Proteins 0.000 description 1
• 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 1
• 102100040898 Growth/differentiation factor 11 Human genes 0.000 description 1
• 102100040896 Growth/differentiation factor 15 Human genes 0.000 description 1
• 102100040892 Growth/differentiation factor 2 Human genes 0.000 description 1
• 102100035364 Growth/differentiation factor 3 Human genes 0.000 description 1
• 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
• 102100035363 Growth/differentiation factor 7 Human genes 0.000 description 1
• 108050006583 Growth/differentiation factor 8 Proteins 0.000 description 1
• 102100035970 Growth/differentiation factor 9 Human genes 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 208000028782 Hereditary disease Diseases 0.000 description 1
• 101000785776 Homo sapiens Artemin Proteins 0.000 description 1
• 101000695367 Homo sapiens Bone morphogenetic protein 10 Proteins 0.000 description 1
• 101000695360 Homo sapiens Bone morphogenetic protein 15 Proteins 0.000 description 1
• 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
• 101000762375 Homo sapiens Bone morphogenetic protein 3 Proteins 0.000 description 1
• 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 1
• 101000899388 Homo sapiens Bone morphogenetic protein 5 Proteins 0.000 description 1
• 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 1
• 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 description 1
• 101000899364 Homo sapiens Bone morphogenetic protein 8A Proteins 0.000 description 1
• 101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 description 1
• 101000893552 Homo sapiens Embryonic growth/differentiation factor 1 Proteins 0.000 description 1
• 101000893563 Homo sapiens Growth/differentiation factor 10 Proteins 0.000 description 1
• 101000893545 Homo sapiens Growth/differentiation factor 11 Proteins 0.000 description 1
• 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 description 1
• 101000893585 Homo sapiens Growth/differentiation factor 2 Proteins 0.000 description 1
• 101001023986 Homo sapiens Growth/differentiation factor 3 Proteins 0.000 description 1
• 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 1
• 101001023964 Homo sapiens Growth/differentiation factor 6 Proteins 0.000 description 1
• 101001023968 Homo sapiens Growth/differentiation factor 7 Proteins 0.000 description 1
• 101000886562 Homo sapiens Growth/differentiation factor 8 Proteins 0.000 description 1
• 101001075110 Homo sapiens Growth/differentiation factor 9 Proteins 0.000 description 1
• 101001076604 Homo sapiens Inhibin alpha chain Proteins 0.000 description 1
• 101001054725 Homo sapiens Inhibin beta B chain Proteins 0.000 description 1
• 101001054832 Homo sapiens Inhibin beta C chain Proteins 0.000 description 1
• 101001054830 Homo sapiens Inhibin beta E chain Proteins 0.000 description 1
• 101001004623 Homo sapiens Lactase-like protein Proteins 0.000 description 1
• 101000967920 Homo sapiens Left-right determination factor 1 Proteins 0.000 description 1
• 101000967918 Homo sapiens Left-right determination factor 2 Proteins 0.000 description 1
• 101100241084 Homo sapiens NRTN gene Proteins 0.000 description 1
• 101001136670 Homo sapiens Persephin Proteins 0.000 description 1
• 101001116302 Homo sapiens Platelet endothelial cell adhesion molecule Proteins 0.000 description 1
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 1
• 101000635958 Homo sapiens Transforming growth factor beta-2 proprotein Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 230000006133 ISGylation Effects 0.000 description 1
• 101150002416 Igf2 gene Proteins 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102100025885 Inhibin alpha chain Human genes 0.000 description 1
• 102100027004 Inhibin beta A chain Human genes 0.000 description 1
• 102100027003 Inhibin beta B chain Human genes 0.000 description 1
• 102100026812 Inhibin beta C chain Human genes 0.000 description 1
• 102100026818 Inhibin beta E chain Human genes 0.000 description 1
• 108010001127 Insulin Receptor Proteins 0.000 description 1
• 102000003746 Insulin Receptor Human genes 0.000 description 1
• 229930194542 Keto Chemical class 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• ZFOMKMMPBOQKMC-KXUCPTDWSA-N L-pyrrolysine Chemical compound C[C@@H]1CC=N[C@H]1C(=O)NCCCC[C@H]([NH3+])C([O-])=O ZFOMKMMPBOQKMC-KXUCPTDWSA-N 0.000 description 1
• ZKZBPNGNEQAJSX-REOHCLBHSA-N L-selenocysteine Chemical compound [SeH]C[C@H](N)C(O)=O ZKZBPNGNEQAJSX-REOHCLBHSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 108091008555 LTK receptors Proteins 0.000 description 1
• 102100025640 Lactase-like protein Human genes 0.000 description 1
• 102100040508 Left-right determination factor 1 Human genes 0.000 description 1
• 102100040511 Left-right determination factor 2 Human genes 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 102100032114 Lumican Human genes 0.000 description 1
• 108010076371 Lumican Proteins 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 206010025421 Macule Diseases 0.000 description 1
• 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 1
• 108091008553 MuSK receptors Proteins 0.000 description 1
• 102100030173 Muellerian-inhibiting factor Human genes 0.000 description 1
• 101710122877 Muellerian-inhibiting factor Proteins 0.000 description 1
• 206010062575 Muscle contracture Diseases 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 206010029113 Neovascularisation Diseases 0.000 description 1
• 102100023206 Neuromodulin Human genes 0.000 description 1
• 101710144282 Neuromodulin Proteins 0.000 description 1
• 102000003683 Neurotrophin-4 Human genes 0.000 description 1
• 102100021584 Neurturin Human genes 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 102000004264 Osteopontin Human genes 0.000 description 1
• 108010081689 Osteopontin Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 229930012538 Paclitaxel Natural products 0.000 description 1
• 208000031481 Pathologic Constriction Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 208000006735 Periostitis Diseases 0.000 description 1
• 102100036660 Persephin Human genes 0.000 description 1
• 108010009711 Phalloidine Proteins 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 239000004721 Polyphenylene oxide Substances 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
• 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 108091008551 RET receptors Proteins 0.000 description 1
• 108091008554 ROR receptors Proteins 0.000 description 1
• 238000010240 RT-PCR analysis Methods 0.000 description 1
• 108091008552 RYK receptors Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 208000001647 Renal Insufficiency Diseases 0.000 description 1
• 206010061481 Renal injury Diseases 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 201000001718 Roberts syndrome Diseases 0.000 description 1
• 208000012474 Roberts-SC phocomelia syndrome Diseases 0.000 description 1
• 101150086605 Runx2 gene Proteins 0.000 description 1
• 230000006295 S-nitrosylation Effects 0.000 description 1
• 101700032040 SMAD1 Proteins 0.000 description 1
• 241000605112 Scapanulus oweni Species 0.000 description 1
• 102000005450 TIE receptors Human genes 0.000 description 1
• 108010006830 TIE receptors Proteins 0.000 description 1
• 102000007000 Tenascin Human genes 0.000 description 1
• 108010008125 Tenascin Proteins 0.000 description 1
• 208000021945 Tendon injury Diseases 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 1
• 102100030737 Transforming growth factor beta-2 proprotein Human genes 0.000 description 1
• 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
• 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 239000006035 Tryptophane Substances 0.000 description 1
• 102100037236 Tyrosine-protein kinase receptor UFO Human genes 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 238000005411 Van der Waals force Methods 0.000 description 1
• 208000024248 Vascular System injury Diseases 0.000 description 1
• 208000012339 Vascular injury Diseases 0.000 description 1
• 102000003970 Vinculin Human genes 0.000 description 1
• 108090000384 Vinculin Proteins 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 102000013814 Wnt Human genes 0.000 description 1
• 108050003627 Wnt Proteins 0.000 description 1
• 238000002679 ablation Methods 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 229960001138 acetylsalicylic acid Drugs 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 208000037919 acquired disease Diseases 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 230000006154 adenylylation Effects 0.000 description 1
• 210000002867 adherens junction Anatomy 0.000 description 1
• 230000009815 adipogenic differentiation Effects 0.000 description 1
• 206010064930 age-related macular degeneration Diseases 0.000 description 1
• 230000032683 aging Effects 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 210000004712 air sac Anatomy 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 210000002383 alveolar type I cell Anatomy 0.000 description 1
• 210000002588 alveolar type II cell Anatomy 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 238000002399 angioplasty Methods 0.000 description 1
• 208000010123 anthracosis Diseases 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 229940127218 antiplatelet drug Drugs 0.000 description 1
• 210000000709 aorta Anatomy 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 230000010516 arginylation Effects 0.000 description 1
• 210000001188 articular cartilage Anatomy 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 230000017047 asymmetric cell division Effects 0.000 description 1
• 210000003050 axon Anatomy 0.000 description 1
• 239000002585 base Substances 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 239000000560 biocompatible material Substances 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 150000001615 biotins Chemical class 0.000 description 1
• 230000006287 biotinylation Effects 0.000 description 1
• 238000007413 biotinylation Methods 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
• 230000010478 bone regeneration Effects 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 210000000233 bronchiolar non-ciliated Anatomy 0.000 description 1
• 208000023367 bronchiolitis obliterans with obstructive pulmonary disease Diseases 0.000 description 1
• 230000006242 butyrylation Effects 0.000 description 1
• 238000010514 butyrylation reaction Methods 0.000 description 1
• 230000002308 calcification Effects 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 230000021235 carbamoylation Effects 0.000 description 1
• 150000007942 carboxylates Chemical class 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
• 125000002843 carboxylic acid group Chemical group 0.000 description 1
• 231100000357 carcinogen Toxicity 0.000 description 1
• 239000003183 carcinogenic agent Substances 0.000 description 1
• 230000003848 cartilage regeneration Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000033026 cell fate determination Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000011748 cell maturation Effects 0.000 description 1
• 210000002421 cell wall Anatomy 0.000 description 1
• 210000003850 cellular structure Anatomy 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 230000003399 chemotactic effect Effects 0.000 description 1
• 239000005482 chemotactic factor Substances 0.000 description 1
• 230000004087 circulation Effects 0.000 description 1
• 230000006329 citrullination Effects 0.000 description 1
• GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
• 229960003009 clopidogrel Drugs 0.000 description 1
• 229940096422 collagen type i Drugs 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 230000006854 communication Effects 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 208000006111 contracture Diseases 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 210000004087 cornea Anatomy 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000002447 crystallographic data Methods 0.000 description 1
• 230000006240 deamidation Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 210000003074 dental pulp Anatomy 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 238000000151 deposition Methods 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 1
• 230000008278 dynamic mechanism Effects 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 230000009881 electrostatic interaction Effects 0.000 description 1
• 230000006330 eliminylation Effects 0.000 description 1
• 230000035616 enchondral ossification Effects 0.000 description 1
• 210000003038 endothelium Anatomy 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 210000002336 epiblast cell Anatomy 0.000 description 1
• 210000002514 epidermal stem cell Anatomy 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 235000019197 fats Nutrition 0.000 description 1
• 210000000630 fibrocyte Anatomy 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 230000003325 follicular Effects 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 239000000446 fuel Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 230000006251 gamma-carboxylation Effects 0.000 description 1
• 230000007045 gastrulation Effects 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 230000004022 gliogenesis Effects 0.000 description 1
• 102000034238 globular proteins Human genes 0.000 description 1
• 108091005896 globular proteins Proteins 0.000 description 1
• 210000001282 glomerular podocyte Anatomy 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 235000001727 glucose Nutrition 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 230000006237 glutamylation Effects 0.000 description 1
• 230000035430 glutathionylation Effects 0.000 description 1
• 230000036252 glycation Effects 0.000 description 1
• 230000006095 glypiation Effects 0.000 description 1
• 210000002175 goblet cell Anatomy 0.000 description 1
• 210000001126 granulation tissue Anatomy 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 210000004919 hair shaft Anatomy 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 230000023597 hemostasis Effects 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 210000003035 hyaline cartilage Anatomy 0.000 description 1
• BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 150000002431 hydrogen Chemical group 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 238000012744 immunostaining Methods 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 208000000509 infertility Diseases 0.000 description 1
• 230000036512 infertility Effects 0.000 description 1
• 231100000535 infertility Toxicity 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 108010019691 inhibin beta A subunit Proteins 0.000 description 1
• 230000002608 insulinlike Effects 0.000 description 1
• 230000008611 intercellular interaction Effects 0.000 description 1
• 210000002570 interstitial cell Anatomy 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 230000006662 intracellular pathway Effects 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 230000006122 isoprenylation Effects 0.000 description 1
• 230000000366 juvenile effect Effects 0.000 description 1
• 125000000468 ketone group Chemical class 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 201000006370 kidney failure Diseases 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 210000005246 left atrium Anatomy 0.000 description 1
• 210000002332 leydig cell Anatomy 0.000 description 1
• 230000006144 lipoylation Effects 0.000 description 1
• 238000009630 liquid culture Methods 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 231100000864 loss of vision Toxicity 0.000 description 1
• 208000018769 loss of vision Diseases 0.000 description 1
• PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000017538 malonylation Effects 0.000 description 1
• 210000004997 mammalian reproductive system Anatomy 0.000 description 1
• 210000004373 mandible Anatomy 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 210000002752 melanocyte Anatomy 0.000 description 1
• 210000000716 merkel cell Anatomy 0.000 description 1
• 210000003584 mesangial cell Anatomy 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 229910001092 metal group alloy Inorganic materials 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 210000004115 mitral valve Anatomy 0.000 description 1
• 108091005601 modified peptides Proteins 0.000 description 1
• 230000009456 molecular mechanism Effects 0.000 description 1
• 238000012900 molecular simulation Methods 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 210000001074 muscle attachment cell Anatomy 0.000 description 1
• 210000005012 myelin Anatomy 0.000 description 1
• 210000001167 myeloblast Anatomy 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 208000031225 myocardial ischemia Diseases 0.000 description 1
• 210000000107 myocyte Anatomy 0.000 description 1
• 230000001114 myogenic effect Effects 0.000 description 1
• 210000001087 myotubule Anatomy 0.000 description 1
• 230000007498 myristoylation Effects 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 230000009527 neddylation Effects 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 210000000276 neural tube Anatomy 0.000 description 1
• 210000003757 neuroblast Anatomy 0.000 description 1
• 230000001272 neurogenic effect Effects 0.000 description 1
• 229940097998 neurotrophin 4 Drugs 0.000 description 1
• 102000045246 noggin Human genes 0.000 description 1
• 108700007229 noggin Proteins 0.000 description 1
• 230000037311 normal skin Effects 0.000 description 1
• 210000003458 notochord Anatomy 0.000 description 1
• 230000005257 nucleotidylation Effects 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 210000004248 oligodendroglia Anatomy 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 238000000847 optical profilometry Methods 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 230000001582 osteoblastic effect Effects 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
• 229960001592 paclitaxel Drugs 0.000 description 1
• 230000003076 paracrine Effects 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 235000015927 pasta Nutrition 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000007310 pathophysiology Effects 0.000 description 1
• 238000000059 patterning Methods 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
• 150000002972 pentoses Chemical class 0.000 description 1
• 230000009984 peri-natal effect Effects 0.000 description 1
• 210000003460 periosteum Anatomy 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 235000021317 phosphate Nutrition 0.000 description 1
• 239000002953 phosphate buffered saline Substances 0.000 description 1
• 230000005261 phosphopantetheinylation Effects 0.000 description 1
• BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
• 108091008695 photoreceptors Proteins 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
• 210000000557 podocyte Anatomy 0.000 description 1
• 229920000962 poly(amidoamine) Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 230000001884 polyglutamylation Effects 0.000 description 1
• 230000019474 polyglycylation Effects 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 230000006267 polysialylation Effects 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 230000017363 positive regulation of growth Effects 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 238000003822 preparative gas chromatography Methods 0.000 description 1
• 230000003658 preventing hair loss Effects 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000006289 propionylation Effects 0.000 description 1
• 238000010515 propionylation reaction Methods 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000005180 public health Effects 0.000 description 1
• 210000003492 pulmonary vein Anatomy 0.000 description 1
• 230000017614 pupylation Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 229940043131 pyroglutamate Drugs 0.000 description 1
• 230000006340 racemization Effects 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000006722 reduction reaction Methods 0.000 description 1
• 230000001084 renoprotective effect Effects 0.000 description 1
• 230000008672 reprogramming Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000029058 respiratory gaseous exchange Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000000250 revascularization Effects 0.000 description 1
• 239000002342 ribonucleoside Substances 0.000 description 1
• 210000004918 root sheath Anatomy 0.000 description 1
• 238000005001 rutherford backscattering spectroscopy Methods 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 210000004761 scalp Anatomy 0.000 description 1
• 238000004626 scanning electron microscopy Methods 0.000 description 1
• 238000006748 scratching Methods 0.000 description 1
• 230000002393 scratching effect Effects 0.000 description 1
• 229940055619 selenocysteine Drugs 0.000 description 1
• ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
• 235000016491 selenocysteine Nutrition 0.000 description 1
• 210000001044 sensory neuron Anatomy 0.000 description 1
• 150000003354 serine derivatives Chemical class 0.000 description 1
• 210000000717 sertoli cell Anatomy 0.000 description 1
• 230000014639 sexual reproduction Effects 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• 229960002930 sirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
• 230000037075 skin appearance Effects 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 230000008491 skin homeostasis Effects 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 210000001082 somatic cell Anatomy 0.000 description 1
• 230000000392 somatic effect Effects 0.000 description 1
• 210000001988 somatic stem cell Anatomy 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 210000000603 stem cell niche Anatomy 0.000 description 1
• 230000036262 stenosis Effects 0.000 description 1
• 208000037804 stenosis Diseases 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 230000035322 succinylation Effects 0.000 description 1
• 238000010613 succinylation reaction Methods 0.000 description 1
• 230000019635 sulfation Effects 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 230000010741 sumoylation Effects 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 230000002889 sympathetic effect Effects 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 230000001360 synchronised effect Effects 0.000 description 1
• 210000001258 synovial membrane Anatomy 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 150000007970 thio esters Chemical class 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 201000005665 thrombophilia Diseases 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 102000027257 transmembrane receptors Human genes 0.000 description 1
• 108091008578 transmembrane receptors Proteins 0.000 description 1
• 229960004799 tryptophan Drugs 0.000 description 1
• 210000004926 tubular epithelial cell Anatomy 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 210000003556 vascular endothelial cell Anatomy 0.000 description 1
• 229940124676 vascular endothelial growth factor receptor Drugs 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 230000032665 vasculature development Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000004393 visual impairment Effects 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• 210000001325 yolk sac Anatomy 0.000 description 1